Affective disorders accompanied by cognitive impairment in inpatients with cardiology: a clinical and pathopsychological study



如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Objective: to study the structure of affective disorders and comorbid cognitive impairment in inpatients with cardiology.

Materials and methods: the study included inpatients with cardiology with comorbid mental disorders (N=121). Clinical-psychopathological, psychometric methods, and descriptive statistics were used.

Results: the proportion of patients with comorbid affective and cognitive disorders (N=47) was 38.3% of the total number of inpatients with cardiology diagnosed with mental disorders. The structure of emotional disorders was dominated by pathology of the emotional sphere of organic nature of vascular genesis in accordance with the ICD-10 criteria for disorders of the headings F06.4, F06.3. (85.1%).

Conclusions: data were obtained on the mechanisms of development of comorbid emotional and cognitive symptoms in cardiovascular diseases (CVD).

 

全文:

受限制的访问

作者简介

Irina Mashkova

-

编辑信件的主要联系方式.
Email: mashkovairina2018@gmail.com
ORCID iD: 0000-0002-4342-671X

For correspondence: Irina Y. Mashkova, MD, PhD, Cand. of Sci. (Med.), Associate Professor of the Department of Psychiatry and Narcology, Moscow State University of Medicine and Dentistry named after А.I. Evdokimov of the Ministry of Healthcare of the Russian Federation

俄罗斯联邦

Galina Alyoshkina

Russian University of Medicine

Email: aleshkina-ga@yandex.ru
ORCID iD: 0000-0001-7028-8669
SPIN 代码: 7477-8598

MD, Dr. Sci. (Medicine), Professor

俄罗斯联邦, Moscow

Yury Vasyuk

Russian University of Medicine

Email: yvasyuk@yandex.ru
ORCID iD: 0000-0003-2913-9797
SPIN 代码: 2265-5331
Scopus 作者 ID: 6508291333
Researcher ID: G-1772-2013

MD, Dr. Sci. (Med.), Professor, Scientific Secretary, Head of the Department of Hospital Therapy No. 1, Honored Doctor of the Russian Federation, Honored Worker of Higher Education of the Russian Federation

俄罗斯联邦, 20 building 1 Delegatskaya St., Moscow, 127473

Leonid Bardenshteyn

Russian University of Medicine

Email: barden@mail.ru
ORCID iD: 0000-0002-1171-5517
SPIN 代码: 9289-9177

MD, Dr. Sci. (Medicine), Professor

俄罗斯联邦, Moscow

Dmitriy Smirnov;

Российский университет медицины

Email: dsmirnov@mail.ru
ORCID iD: 0009-0009-9151-0826
俄罗斯联邦

参考

  1. Bardenshtein L.M., Torchinov A.M., Umakhanova M.M., Kharkharova M.A. Clinical typology of depressive disorders in women in the perimenopausal period. Allergology and immunology. 2005. Vol. 6. No. 2. P. 269-275.
  2. Bobrov A.E., Starostina E.G., Agamamedova I.N., Volodina M.N., Karacheva Yu.V., Nikitina T.E., Parpara M.A., Subbotnikova O.A., Tsarenko D.M., Nouven A., Lloyd K., Sartorius N. Mental disorders in type 2 diabetes mellitus. Journal of Neurology and Psychiatry named after S.S. Korsakov. 2021;121(7):22-30.]. 3. Vasyuk Yu. A., Dovzhenko T. V., Dubrovskaya T. I. et al. Features of arterial hypertension in patients with obesity and anxiety-depressive disorders. Therapeutic archive. 2021; 93 (1): 94–99. doi: 10.26442/00403660.2021.01.200567.
  3. Birk, J. L., Kronish, I. M., Moise, N. et al. (2019). Depression and multimorbidity: Considering temporal characteristics of the associations between depression and multiple chronic diseases. Health Psychology, 38(9), 802–811
  4. Matskevich S. A., M. I. Belskaya Comorbidity of cardiovascular diseases and anxiety-depressive disorders // Medical news. - 2018. – No12. – pp. 4-6.
  5. Poole L, Steptoe A. Depressive symptoms predict incident chronic disease burden 10 years later: findings from the English Longitudinal Study of Ageing (ELSA). J Psychosom Res. 2018;113:30-36. doi: 10.1016/j.jpsychores.2018.07.009
  6. Koyanagi A et al. Mortality in unipolar depression preceding and following chronic somatic diseases. Acta Psychiatr Scand. 2018;138(6):500-508. doi: 10.1111/acps.12899
  7. Sobennikov V.S., Vinokurov E.V., Rychkova L.V., Sobennikova V.V. Emotional dysregulation as a factor in psychosomatic disorders in depression and cardiovascular pathology (analytical review of foreign literature). Acta biomedica scientifica. 2019; 4(1): 87-92. doi: 10.29413/ABS.2019-4.1.13
  8. Willmott R. et al. An investigation of neuropsychiatric symptoms, contextual factors, and antidepressant treatment as risk factors for dementia development in people with mild cognitive impairment //International Journal of Geriatric Psychiatry. - 2024. - Vol. 39. - No. 5. - P. e6097.
  9. Willmott, R., Martin West, I., Yung, P., Giri Shankar, V., Perera, G., Tsamakis, K., ... & Mueller, C. (2024). An investigation of neuropsychiatric symptoms, contextual factors, and antidepressant treatment as risk factors for dementia development in people with mild cognitive impairment. International Journal of Geriatric Psychiatry, 39(5), e6097
  10. Ostroumova O.D., Parfenov V.A., Ostroumova T.M., Yakhno N.N., Chazova I.E., Bogolepova A.N., Galyavich A.S., Geraskina L.A., Emelin A.Yu., Zakharov V.V., Kislyak O.A., Kulesh A.A., Levin O.S., Podzolkov V.I., Privalova E.V., Shikh E.V. Expert consensus. The effect of antihypertensive therapy on cognitive functions. Systemic hypertension. 2021;18(1):5-12. https://doi.org/10.26442/2075082X.2021.1.200575
  11. Scuteri, A., Benetos, A., Sierra, C., Coca, A., Chicherio, C., Frisoni, G. B., & Cunha, P. G. (2021). Routine assessment of cognitive function in older patients with hypertension seen by primary care physicians: why and how—a decision-making support from the working group on ‘hypertension and the brain’of the European Society of Hypertension and from the European Geriatric Medicine Society. Journal of hypertension, 39(1), 90-100.
  12. Reikhert L.V., Kicherova O.A., Reikhert L.I., Doyan Yu.I. State of cognitive function in patients with permanent atrial fibrillation // Ural University Medicine. 2018. Vol. 4, N 1 (12). P. 83-85.
  13. Krupenin PM, Voskresenskaya ON, Napalkov DA, Sokolova AA. Cognitive impairment and small vessel disease in atrial fibrillation. Neurology, neuropsychiatry, psychosomatics. 2022;14(6):55–62. doi: 10.14412/2074-2711-2022- 6-55-6238
  14. Brown R., Benveniste H., Black S.E., Charpak S., Dichgans M., Joutel A. et al. Understanding the role of the perivascular space in cerebral small vessel disease. Cardiovasc Res. 2018;114(11):1462–1473. doi: 10.1093/cvr/cvy113. 2020;(8):
  15. Passiak B.S., Liu D., Kresge H.A., Cambronero F.E., Pechman K.R., Osborn K.E. et al. Perivascular spaces contribute to cognition beyond other small vessel disease markers. Neurology. 2019;92(12):e1309–e1321. doi: 10.1212/WNL.0000000000007124
  16. Neznanov, N. G. Negative and cognitive disorders in endogenous psychoses: diagnostics, clinical features, therapy / Neznanov N. G, Ivanov M. V. // M.: 2nd ed., suppl. MEDpress-inform. – 2023.– P. 328
  17. Ostroumova O.D., Ostroumova T.M., Dzamikhov K.K. Arterial hypertension and cognitive impairment: a multimodal approach to patient management and the possibilities of nicergoline. Medical Council. 2020;(8):72–80. doi: 10.21518/2079-701X-2020-8-72-80.
  18. Sekhon S, Marwaha R. Depressive Cognitive Disorders. Updated 2023 Jul 3. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2024 Jan. Available at: https://www.ncbi.nlm.nih.gov/books/NBK559256/
  19. Petrova N. N. Depression in the structure of various mental disorders and cognitive impairment // Psychiatrist
  20. Hershey LA, Olszewski WA. Ischemic vascular dementia. In: Handbook of Demented Illnesses. Ed. by J.C. Morris. New York etc.: Marcel Dekker, Inc. 1994: 335-351.
  21. Levin O.S., Damulin I.V. Diffuse changes in white matter (leukoaraiosis) and the problem of vascular dementia. In: "Achievements in neurogeriatrics". Ed. by N.N.Yakhno, I.V.Damulin. Moscow: MMA Publishing House. 1995: 189-231.
  22. Gerschmann A., Lehrner J. Depressive symptoms—Not a predictor for five-year mortality in patients with subjective cognitive decline, non-amnestic and amnestic mild cognitive impairment //neuropsychiatrie. – 2024. – P. 1-10.
  23. Gerschmann, A., & Lehrner, J. (2024). Depressive symptoms—Not a predictor for five-year mortality in patients with subjective cognitive decline, non-amnestic and amnestic mild cognitive impairment. neuropsychiatrie, 1-10.]
  24. Jelic V., Kivipelto M., Winblad B. Clinical trials in mild cognitive impairment: lessons for the future // J. Neurol. Neurosurg. Psychiatry. 2006. Vol. 77. No. 4. P. 429–438.
  25. Knopman D.S. Current treatment of mild cognitive impairment and Alzheimer’s disease // Curr. Neurol. Neurosci. Rep. 2006. Vol. 6. No. 5. P. 365–371.
  26. Zakharov V.V. Non-dementia cognitive disorders: classification, main causes and treatment, 2016
  27. Jessen F., Amariglio R.E., van Boxtel M. et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s disease // Alzheimer’s Dement. 2014. Vol. 10. No 6. P. 844–852.
  28. Golland, V.B., Dmitrieva, T.B., Kazakovtsev, B.A., Kontsevoy, V.A., Kozyrev, V.N., Maksutova, A.L., ... & Secrieru, E.M. (1998). Mental and behavioral disorders (F00–F99). Mental and behavioral disorders (F00–F99). (Class V of ICD-10, adapted for use in the Russian Federation). General editors Kazakovtsev B.A., Golland V.B. - M .: Ministry of Health of Russia, 1998. - 512 p.
  29. Fawzi, H. (2023). Hospital Anxiety and Depression Scale (HADS) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.10066477
  30. Bogolepova A.N., Vasenina E.E., Gomzyakova N.A., et al. Clinical guidelines "Cognitive disorders in elderly and senile patients" // Journal of Neurology and Psychiatry named after S.S. Korsakov. 2021. Vol. 121, No. 10 3. P. 6–137. doi: 10.17116/jnevro2021121103].
  31. Agrell B. The clock-drawing test // Age and Ageing. - 1998. - No. 27. - P. 399-403.
  32. Rubinstein S. Ya. Experimental methods of pathopsychology and the experience of their application in the clinic. Moscow: April-Press, Psychotherapy, 2010. 224 p.
  33. Bardenstein L. M. Clinic, dynamics and therapy of dysthymia. In the book: Psychopharmacotherapy of borderline mental disorders Aleksandrovsky Yu. A., Bardenstein L. M., Avedisova A. S. Moscow, 2000, pp. 136-163.
  34. Preobrazhenskaya I. S., Yakhno N. N. Vascular cognitive impairment: clinical manifestations, diagnosis, treatment. Neurological journal, 2007, 12(5): 45-50.
  35. Yakhno N.N., Zakharov V.V., Lokshina A.B. Syndrome of moderate cognitive impairment in cerebrovascular insufficiency. Zhurnal nevrol. i psychiatrist. im. S.S. Korsakov, 2005, 105(2): 13-17.
  36. Fehnel S. E. et al. Patient-centered assessment of cognitive symptoms of depression //CNS spectrums. – 2016. – Vol. 21. – No. 1. – P. 43-52.
  37. Fehnel, S. E., Forsyth, B. H., DiBenedetti, D. B., Danchenko, N., François, C., & Brevig, T. (2016). Patient-centered assessment of cognitive symptoms of depression. CNS spectrums, 21(1), 43-52.
  38. Hammar Å., Lund A., Hugdahl K. Long-lasting cognitive impairment in unipolar major depression: a six months follow-up study // Psychiatry Res. 2003. Vol. 118. No 2. P. 189–196.
  39. Vasenina E. E., Levin O. S. Speech impairment in vascular and neurodegenerative diseases: possibilities of drug and non-drug therapy // Pharmateka. - 2020. - Vol. 27. - No. 3. – P. 38-49.
  40. Voznesenskaya T.G. Non-cognitive neuropsychiatric disorders in cognitive impairment in old age // Neurological journal. 2010. Vol. 15. No. 2. P. 4–18.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Eco-Vector,


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия  ПИ № ФС 77 - 86296 от 11.12.2023 г. 
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ЭЛ № ФС 77 - 80632 от 15.03.2021 г.